510(k) Report

510(k) · Cleared

Cleared

Ibm 2991 Blood Cell Processor Mod. 1 & 2

K812355510(k) TraditionalCleared Sep 9, 198121-day reviewClass II21 CFR 868.5830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intl. Business Machines · CAC Apparatus, Autotransfusion

Cleared on Sep 9, 1981 after a 21-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 2 later devices descend from it.

Decided
Sep 9, 1981
Review
21 days
Class
Class II
Product code
CAC
Recalls
None
Predicates
0

2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 1997: 1 descendant cleared1999: 1 descendant cleared19801990200020102020
  1. This deviceK812355 Ibm 2991 Blood Cell Processor Mod. 1 & 2Intl. Business Machines · 1981
  2. Descendant · cites it directly · 0 of its ownK982660 Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp. · 1999
  3. Descendant · cites it directly · 0 of its ownK962475 Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp. · 1997

Most influential descendants

Showing 2 of 2 · See all
  • K982660Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp. · 1999 · cites it directly0descendants
  • K962475Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp. · 1997 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K812355Ibm 2991 Blood Cell Processor Mod. 1 & 2Intl. Business Machines1981—
+1K982660Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp.1999—
+1K962475Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp.1997—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199710
199910
FIG. 1 — Lineage of K812355, 1981–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAC device

  1. #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K982660Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp.19990
K962475Orthopedic Perioperative Autotransfusion (Orthopat) SystemTransfusion Technologies Corp.19970

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K982660 (Transfusion Technologies Corp., 1999) has gone furthest, with 0 descendants of its own.

How does its category compare?

All CAC devices

CAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAC

3in 2024

2008: 12010: 42011: 22012: 32013: 12014: 32016: 22017: 12018: 22019: 12020: 12021: 42022: 12023: 22024: 3
2007high 4 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAC

91in 2024

2010: 123 days median2012: 90 days median2014: 269 days median2021: 155 days median2024: 91 days median
2007high 269 (2014) · low 90 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAC

7in 2023

2007: 12008: 52009: 252010: 32011: 32013: 92017: 22018: 22019: 232023: 7, 2 Class I
2007high 25 (2009) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAC

128in 2025

2007: 352008: 122009: 682010: 1152011: 9392012: 2492013: 1532014: 902015: 872016: 732017: 882018: 872019: 642020: 1082021: 732022: 652023: 392024: 1292025: 128
2007high 939 (2011) · low 12 (2008)2025

MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—135
20081—512
20090—2568
201041233115
20112—3939
20123900249
20131—9153
20143269090
20150—087
20162—073
20171—288
20182—287
20191—2364
20201—0108
20214155073
20221—065
20232—7 (2)39
20243910129
20250—0128
20260—0—
Cite this page

510(k) Report. “K812355: Ibm 2991 Blood Cell Processor Mod. 1 & 2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K812355

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026